{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T03:14:32Z","timestamp":1787973272860,"version":"build-2784847793"},"reference-count":139,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.dld.2019.09.017","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:44:29Z","timestamp":1574196269000},"page":"21-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA)"],"prefix":"10.1016","volume":"52","author":[{"given":"Gianni","family":"Testino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teo","family":"Vignoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Patussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Scafato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2019.09.017_bib0005","series-title":"Global status report on alcohol and health","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.dld.2019.09.017_bib0010","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","author":"GBD 2016 Alcohol Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.09.017_bib0015","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.dld.2019.09.017_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cld.2018.09.011","article-title":"Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease","volume":"23","author":"Axley","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cld.168","article-title":"Epidemiology of ALD","volume":"2","author":"Singal","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0030","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dld.2019.09.017_bib0035","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1056\/NEJMra1715733","article-title":"Alcohol use in patients with chronic liver disease","volume":"379","author":"Fuster","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/hep.30358","article-title":"Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease","volume":"70","author":"Caputo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0045","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4254\/wjh.v8.i31.1295","article-title":"Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infection","volume":"8","author":"Fuster","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0050","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the prevalence of hepatitis C virus infection, non-alcoholic steatoepatitis and alcoholic liver disease among patients with cirrhosis or liver failure on the waiting list for liver transplantation","volume":"152","author":"Ditah","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0055","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(17)32866-0","article-title":"Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK","volume":"391","author":"Williams","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.09.017_bib0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cld.2018.09.007","article-title":"Liver transplantation for alcoholic liver disease. An update","volume":"23","author":"Godfrey","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0065","series-title":"National programme of guidelines","author":"Istituto Superiore di Sanit\u00e0","year":"2002"},{"key":"10.1016\/j.dld.2019.09.017_bib0070","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2019.09.017_bib0075","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence-publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2019.09.017_bib0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/rccm.200602-197ST","article-title":"An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations","volume":"174","author":"Sch\u00fcnemann","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0090","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"O\u2019Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.dld.2016.12.027","article-title":"Common issues in the management of patients in the waiting list and after liver transplantation","volume":"49","author":"Burra","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0105","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.dld.2018.11.035","article-title":"Hepatic encephalopathy 2018: a clinical practice guideline by the Italian Association for the Study of the Liver (AISF)","volume":"51","author":"Montagnese","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5009\/gnl15419","article-title":"Evaluation and management of hepatic encephalopathy: current status and future directions","volume":"10","author":"Suraweera","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2019.09.017_bib0120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline","volume":"61","author":"European Association for the Study of the Liver","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifamixin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s11011-012-9325-7","article-title":"A patients and caregivers perspective on hepatic encephalopathy","volume":"27","author":"Montagnese","year":"2012","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0135","first-page":"138","article-title":"Liver transplantation for alcoholic liver disease in Europe: a study from ELTR (European Liver Transplant Registry)","volume":"10","author":"Burra","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0140","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/hepr.12065","article-title":"Role of 6-month abstinence rule in living donor liver transplantation for patients with alcoholic liver disease","volume":"43","author":"Kawaguchi","year":"2013","journal-title":"Hepatol Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0145","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.3748\/wjg.v20.i40.14642","article-title":"Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement","volume":"20","author":"Testino","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0150","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/alcalc\/agx099","article-title":"Living donor liver transplantation for alcoholic liver disease","volume":"53","author":"Braun","year":"2018","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.09.017_bib0155","first-page":"164","article-title":"Doctors practicing alternative medicine. The legal considerations","volume":"12","author":"Tse","year":"2006","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.dld.2019.09.017_bib0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0165","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1007\/s001470050320","article-title":"Long term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease","volume":"13","author":"Burra","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0170","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ajg.2009.226","article-title":"A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation","volume":"104","author":"Tandon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0399-8320(04)95146-9","article-title":"Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease","volume":"28","author":"Miguet","year":"2004","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.dld.2019.09.017_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-8278(01)00228-8","article-title":"Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing","volume":"36","author":"Veldt","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0185","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1572-0241.2007.01691.x","article-title":"A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease","volume":"103","author":"Kotlyar","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2015.10.006","article-title":"EASL clinical practice guidelines: liver transplantation","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1530-0277.1998.tb03681.x","article-title":"A model to examine the validity of the 6-month abstinence criterion for liver transplantation","volume":"22","author":"Yates","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/alcalc\/agu096","article-title":"Assessing and treating alcohol relapse risk in liver transplantation candidates","volume":"50","author":"Dom","year":"2015","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.09.017_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrgastro.2013.247","article-title":"Liver transplantation for alcoholic liver disease","volume":"11","author":"Lucey","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0210","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1572-0241.2007.01079.x","article-title":"Negative impact of the novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center","volume":"102","author":"Dumortier","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0215","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13243","article-title":"The multidisciplinary support in preventing alcohol relapse after liver transplantation: a single centre experience","volume":"32","author":"Attilia","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0220","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0225","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/tri.12756","article-title":"Good outcome after liver transplantation for ALD without a 6 months abstinence rule prior to transplantation including post-transplant CDT monitoring for alcohol relapse assessment \u2014 a retrospective study","volume":"29","author":"Kollmann","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0230","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/liv.13755","article-title":"Specific issues concerning the management of patients on the waiting list and after liver transplantation","volume":"38","author":"Burra","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0235","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1111\/ajt.13408","article-title":"A multistep, consensus-based approach to organ allocation in liver transplantation: toward a \u201cBlended Principal Model\u201d","volume":"15","author":"Cillo","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12072-017-9790-5","article-title":"New paradigms in management of alcoholic hepatitis: a review","volume":"11","author":"Sidhu","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000444545","article-title":"Pathogenesis and management of alcoholic liver disease","volume":"34","author":"Farooq","year":"2016","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0250","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0255","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0260","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1053\/j.gastro.2016.02.074","article-title":"Treatment of severe alcoholic hepatitis","volume":"15","author":"Thursz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0265","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.dld.2019.09.017_bib0270","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0275","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hep.30056","article-title":"Acute on chronic liver failure: getting ready for prime-time","volume":"68","author":"Bajaj","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0280","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward a improved definition of acute on chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0285","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/MCG.0000000000000823","article-title":"Severity and outcome of acute on chronic liver failure is dependent on the etiology of acute hepatic insult: analysis of 368 patients","volume":"51","author":"Shalimar","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0290","doi-asserted-by":"crossref","first-page":"290","DOI":"10.23736\/S0026-4806.17.05431-3","article-title":"Acute alcoholic hepatitis: a literature review and proposal of treatment","volume":"109","author":"Testino","year":"2018","journal-title":"Minerva Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0295","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation Score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0300","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0305","first-page":"584","article-title":"Recurrent severe alcoholic hepatitis: clinical characteristics and outcomes","volume":"38","author":"Potts","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0310","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute on chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0315","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0320","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jhep.2018.02.022","article-title":"The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis","volume":"69","author":"Serst\u00e8","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2016.08.047","article-title":"Medical management of severe alcoholic hepatitis: expert review from the clinical practice updates committee of the AGA Institute","volume":"15","author":"Mitchell","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0330","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN guidelines on enteral nutrition: liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.dld.2019.09.017_bib0335","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.gastro.2015.12.038","article-title":"Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids","volume":"150","author":"Moreno","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0340","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/apt.13549","article-title":"Review article: sarcopenia in cirrhosis-aetiology, implications and potential therapeutic interventions","volume":"43","author":"Sinclair","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.017_bib0345","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0350","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.28530","article-title":"Alcoholic hepatitis: translational approachs to develop targeted therapies","volume":"64","author":"Mandrekar","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOG.0000000000000359","article-title":"Alcoholic hepatitis: current trends in management","volume":"33","author":"Aday","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0360","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis. STOPAH trial","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0365","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or Placebo\u2014a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0370","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis\u2014a randomized clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0375","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0380","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0385","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2018.10.026","article-title":"Current trials and novel therapeutic targets for alcoholic hepatitis","volume":"70","author":"Singal","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2017.06.007","article-title":"Targeting inflammation for the treatment of alcoholic liver disease","volume":"180","author":"Xu","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.017_bib0400","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jhep.2018.10.019","article-title":"Microbiome as a therapeutic target in alcohol-related liver disease","volume":"70","author":"Sarin","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0405","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.clinre.2015.05.008","article-title":"Combination therapy: new hope for alcoholic hepatitis?","volume":"39","author":"Gao","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0415","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0420","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cgh.2018.06.013","article-title":"Is granulocyte colony stimulating factor a new treatment for alcoholic hepatitis?","volume":"16","author":"Morgan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.09.017_bib0430","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/lt.24986","article-title":"Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: a multinational, prospective, controlled, randomized trial","volume":"24","author":"Thompson","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.09.017_bib0435","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials","volume":"36","author":"Hmoud","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0440","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0445","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0450","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0455","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/tri.12790","article-title":"Alcohol and liver transplantation: the 6-month abstinence rule is not a dogma","volume":"29","author":"Testino","year":"2016","journal-title":"Transpl Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0460","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/liv.13286","article-title":"Liver transplantation for severe alcoholic hepatitis \u2014 the Con view","volume":"37","author":"Fung","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0465","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/liv.13343","article-title":"Liver transplantation for severe alcoholic hepatitis \u2014 the Pro view","volume":"37","author":"Lucey","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/liv.13248","article-title":"Liver transplantation for patients with alcoholic hepatitis","volume":"37","author":"Artru","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2019.09.017_bib0475","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0480","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.25544","article-title":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database","volume":"55","author":"Singal","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2019.09.017_bib0485","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States \u2014 a single-center experience","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0490","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000001831","article-title":"Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis","volume":"265","author":"Lee","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2019.09.017_bib0495","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jhep.2017.11.027","article-title":"Early liver transplantation for alcoholic hepatitis: ready for primetime?","volume":"68","author":"Kubilium","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0500","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.04.009","article-title":"Outcomes of early liver transplantation for patients with severe alcoholic hepatitis","volume":"155","author":"Lee","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2019.09.017_bib0505","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190823","article-title":"Liver transplantation for alcoholic hepatitis: a systematic review with meta-analysis","volume":"13","author":"Marot","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.dld.2019.09.017_bib0510","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jamcollsurg.2017.12.044","article-title":"Liver transplantation for severe alcoholic hepatitis, updated lessons from the World\u2019s largest series","volume":"226","author":"Weeks","year":"2018","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.dld.2019.09.017_bib0515","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","article-title":"Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3","volume":"67","author":"Artru","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0520","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jhep.2018.12.008","article-title":"Acute-on-chronic liver failure in patients with alcohol-related liver disease","volume":"70","author":"Gustot","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0525","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2018.11.007","article-title":"Liver transplantation for alcoholic hepatitis","volume":"70","author":"Im","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0530","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/ajt.13176","article-title":"Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation","volume":"15","author":"Stroh","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0535","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"10.1016\/j.dld.2019.09.017_bib0540","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol Scale (CIWA-Ar)","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"10.1016\/j.dld.2019.09.017_bib0545","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/lt.23881","article-title":"Assessment of alcohol consumption in liver transplant candidates and recipients: the best combination of the tools available","volume":"20","author":"Piano","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.09.017_bib0550","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/alcalc\/ags109","article-title":"Hair ethyl glucuronide is highly sensitive and specific for detecting moderate-to-heavy drinking in patients with liver disease","volume":"48","author":"Stewart","year":"2013","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.09.017_bib0555","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cld.571","article-title":"Biomarkers for monitoring alcohol use","volume":"8","author":"Cabezas","year":"2018","journal-title":"Clin Liv Dis"},{"key":"10.1016\/j.dld.2019.09.017_bib0560","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.3748\/wjg.v22.i14.3725","article-title":"Biomarkers for detection of alcohol consumption in liver","volume":"22","author":"Staufer","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2019.09.017_bib0565","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1574887113666180227100217","article-title":"Pharmacology, systematic review and recent clinical trials of metadoxine","volume":"13","author":"Di Miceli","year":"2018","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.dld.2019.09.017_bib0570","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1530-0277.2002.tb02543.x","article-title":"Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study","volume":"26","author":"Shpilenya","year":"2002","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0575","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11739-018-1933-8","article-title":"Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol","volume":"14","author":"Caputo","year":"2018","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0580","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/JCP.0b013e318203b36f","article-title":"Efficacy and safety of \u03b3-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report","volume":"31","author":"Caputo","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.dld.2019.09.017_bib0585","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease","volume":"130","author":"Leggio","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0590","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","article-title":"Treatment of alcohol use disorders in patients with alcoholic liver disease","volume":"65","author":"Addolorato","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0595","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1360-0443.2009.02521.x","article-title":"Alcohol-related cirrhosis-early abstinence is a key factor in prognosis, even in the most severe cases","volume":"104","author":"Verrill","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.dld.2019.09.017_bib0600","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14218\/JCTH.2015.00008","article-title":"Diagnosis and management of alcoholic liver disease","volume":"3","author":"Dugum","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0605","article-title":"Opioid antagonists for alcohol dependence","volume":"8","author":"Rosner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.dld.2019.09.017_bib0610","first-page":"447","article-title":"Treatment of alcohol dependence: recent progress and reduction of consumption","volume":"105","author":"Testino","year":"2014","journal-title":"Minerva Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0615","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/apt.13965","article-title":"Review article: pharmacotherapy for alcohol dependence \u2014 the why, the what and the wherefore","volume":"45","author":"Goh","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2019.09.017_bib0620","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/alcalc\/agr017","article-title":"Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized double-blind, placebo-controlled trial","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.09.017_bib0625","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2019.09.017_bib0630","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fpsyt.2018.00474","article-title":"Baclofen for the treatment of alcohol use disorder in patients with liver cirrhosis: 10 years after the first evidence","volume":"9","author":"Mosoni","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.dld.2019.09.017_bib0635","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/MEG.0000000000000922","article-title":"One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience","volume":"29","author":"Barrault","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0640","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1389450116666150518102204","article-title":"Liver disease and hepatocellular carcinoma in alcoholics: the role of anticraving therapy","volume":"17","author":"Borro","year":"2016","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.dld.2019.09.017_bib0645","doi-asserted-by":"crossref","first-page":"369","DOI":"10.23736\/S0026-4806.18.05741-5","article-title":"Addiction disorders: a need for change. Proposal for a new management. Position paper of SIA, Italian Society on Alcohol","volume":"109","author":"Testino","year":"2018","journal-title":"Minerva Med"},{"key":"10.1016\/j.dld.2019.09.017_bib0650","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2019.09.017_bib0655","series-title":"Appropriate use of drug testing in clinical addiction medicine, Consensus Statement","first-page":"1","author":"American Society of Addiction Medicine (ASAM)","year":"2017"},{"key":"10.1016\/j.dld.2019.09.017_bib0660","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/alcalc\/agt170","article-title":"The impact of brief interventions in primary healthcare: a systematic review of reviews","volume":"49","author":"O\u2019Donnell","year":"2014","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.dld.2019.09.017_bib0665","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MOT.0000000000000517","article-title":"Alcohol, liver disease, and transplantation: shifting attitudes and new understanding leads to changes in practice","volume":"23","author":"Mathurin","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0670","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/acer.12980","article-title":"The impact of smoking very low nicotine content cigarettes on alcohol use","volume":"40","author":"Dermody","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0675","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/acer.12997","article-title":"Nicotine and nicotine abstinence do not interfere with GABAa receptor neuroadaptations during alcohol abstinence","volume":"40","author":"Hillmer","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.dld.2019.09.017_bib0680","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1176\/appi.psy.42.1.55","article-title":"Alcohol use following liver transplantation: a comparison of follow-up methods","volume":"42","author":"Dimartini","year":"2001","journal-title":"Psychosomatics"},{"key":"10.1016\/j.dld.2019.09.017_bib0685","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/jlts.2002.33976","article-title":"Liver transplantation for patients on methadone maintenance","volume":"8","author":"Kanchana","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2019.09.017_bib0690","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/152692481002000303","article-title":"Methadone maintenance therapy in liver transplantation","volume":"20","author":"Jiao","year":"2010","journal-title":"Prog Transplant"},{"key":"10.1016\/j.dld.2019.09.017_bib0695","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2018.05.003","article-title":"Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis","volume":"91","author":"Mellinger","year":"2018","journal-title":"J Subst Abuse Treat"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819308370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865819308370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:25Z","timestamp":1761624745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865819308370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":139,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1590865819308370"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2019.09.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis: position paper of the Italian Society on Alcohol (SIA)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2019.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}